Leslie Hudson's Net Worth
$50.7 Million
Who is Leslie Hudson?
Leslie Hudson has an estimated net worth of $50.7 Million. This is based on reported shares across multiple companies, which include HOOPER HOLMES INC, AVI BIOPHARMA INC, NABI BIOPHARMACEUTICALS, and DOV PHARMACEUTICAL INC.
SEC CIK
Leslie Hudson's CIK is 0001321265
Past Insider Trading and Trends
2010 was Leslie Hudson's most active year for acquiring shares with 14 total transactions. Leslie Hudson's most active month to acquire stocks was the month of June. 2010 was Leslie Hudson's most active year for disposing of shares, totalling 62 transactions. Leslie Hudson's most active month to dispose stocks was the month of June. 2006 saw Leslie Hudson paying a total of $880,500.00 for 62,000 shares, this is the most they've acquired in one year. In 2010 Leslie Hudson cashed out on 3,306,765 shares for a total of $2,907,340.07, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HOOPER HOLMES INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5K |
$0.97 | $4,850.00 | 5K |
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVI BIOPHARMA INC (SRPT) Snapshot price: $128.92
Former CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$1.51 | -$154,113.28 | 384.56K |
Jul 30
| |||
Form 4
|
—
|
0
|
$1.46 | -$134,373.70 | 384.56K |
Jul 28
| |||
Form 4
|
—
|
0
|
$1.68 | -$58,727.02 | 384.56K |
Jul 26
| |||
Form 4
|
—
|
0
|
$1.63 | -$71,890.00 | 384.56K |
Jul 23
| |||
Form 4
|
—
|
0
|
$1.63 | -$92,513.12 | 384.56K |
Jul 22
| |||
Form 4
|
—
|
0
|
$1.49 | -$79,083.49 | 384.56K |
Jul 16
| |||
Form 4
|
—
|
0
|
$1.34 | -$98,127.00 | 384.56K |
Jul 9
| |||
Form 4
|
—
|
0
|
$1.19 | -$108,019.41 | 384.56K |
Jul 7
| |||
Form 4
|
—
|
0
|
$1.23 | -$13,060.26 | 384.56K |
Jul 6
| |||
Form 4
| -15.91% | -72.77K |
$1.20 | -$178,402.79 | 384.56K |
Mar 24 - Jul 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
∞
| 457.32K |
—
|
—
| 457.32K |
Feb 8 - Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 333K |
—
|
—
| 333K |
Feb 8
| |||
| No matching records found | |||||||||
NABI BIOPHARMACEUTICALS (VXRT) Snapshot price: $0.88
Interim President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 4
| -30.09% | -24.00K |
$4.08 | -$97,863.40 | 55.76K |
Apr 3
| |||
Form 4
| +578.28% | 68K |
—
|
—
| 79.76K |
Oct 15
| |||
Form 4
| -10.00% | -1.31K |
—
|
—
| 11.76K |
Aug 15
| |||
Form 4
|
∞
| 13.07K |
—
|
—
| 13.07K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DOV PHARMACEUTICAL INC No price found
CEO and President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Jul 28
| |||
| No matching records found | |||||||||